565 Relationships between tezacaftor/ivacaftor administration, gut microbiota composition, and intestinal function in cystic fibrosis
Autor: | Marsh, R., Hanson, L., Ng, C., Mitchell-Whyte, M., Dellschaft, N., Hoad, C., Marciani, L., Gowland, P., Spiller, R., Major, G., Smyth, A., Rivett, D., van der Gast, C. |
---|---|
Zdroj: | In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S314-S315 |
Databáze: | ScienceDirect |
Externí odkaz: |